多中心试验的中心特异性因果推断 - - 在每个参与中心的背景下解释试验证据
Sarah E Robertson1,2,3, Jon A Steingrimsson4, Nina R Joyce5
1CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Statistical methods in medical research
|October 21, 2025
概括
多中心试验可能会产生不适用于单个中心的结果,因为效果修饰器的差异. 本研究介绍了估计中心特定治疗效果的方法,提高了临床研究中当地人口的相关性.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 流行病学 流行病学
背景情况:
- 多中心试验经常面临解释结果的挑战,原因是效果修饰器在各中心的异质性.
- 标准化治疗效果估计可能不适用于个别中心内特定的当地人群.
- 现有的多中心试验分析方法可能需要对中心特定效应做出强有力的假设.
研究的目的:
- 在多中心试验中开发和评估估计中心特定平均治疗效果的方法.
- 为了应对当效果修饰因子因中心而异时,在当地人口的背景下解释试验结果的挑战.
- 提出依赖于比现有可运输性方法更弱的条件的方法.
主要方法:
- 在比流行多中心研究分析条件弱的条件下识别中心特异效应.
- 考虑"中心-结果关联" (取决于共变量和治疗).
- 关于估计中心特异性平均治疗效果的方法的建议,适用于有或没有中心结果关联.
主要成果:
- 提出的方法使得能够估计中心特异性影响,即使在中心成员和结果之间存在关联.
- 当"没有中心结果关联"存在时,这些方法通常更有效,并且需要比相关的可转移性方法更弱的条件.
- 模拟研究证明了拟议方法的性能.
结论:
- 开发的方法提高了多中心试验结果对当地居民的解释性.
- 这些方法为寻求将多中心研究结果概括的研究人员提供了有价值的工具.
- 这些方法用C型肝炎抗病毒抗肝硬化长期治疗试验的数据来说明.
相关概念视频
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:21Causality in Epidemiology
1.5K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.5K
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404
01:29Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K